Eleven P15

About:

Eleven P15 creates diagnostics and treatment for pulmonary fibrosis.

Description:

Eleven P15 creates diagnostics and treatment for pulmonary fibrosis. The company focuses on the development of biomarkers that enable early detection of idiopathic pulmonary fibrosis and the discovery of genetically-targeted therapeutic approaches, enabling physicians to treat and prevent this incurable disease.

Total Funding Amount:

$1.56M

Headquarters Location:

Denver, Colorado, United States

Founded Date:

2016-01-01

Contact Email:

bruce.schroffel(AT)elevenp15.com

Founders:

David Schwartz

Number of Employees:

1-10

Last Funding Date:

2019-11-05

IPO Status:

Private

Industries: